InTest Corporation announced financial results for the fourth quarter and full year ended December 31, 2025. Fourth quarter 2025 revenue was $32.8 million, a 25.1% increase sequentially from Q3 2025, and exceeded the company's guidance range. Q4 2025 diluted earnings per share (EPS) was $0.10, a significant improvement from a net loss of $(0.08) per diluted share in Q3 2025. Gross margin expanded by 350 basis points sequentially to 45.4% in Q4 2025, driven by manufacturing efficiency initiatives and new product sales. Orders remained strong at $37.5 million in Q4 2025, primarily driven by Auto/EV and Life Sciences sectors. Year-end backlog reached $53.9 million, an increase of 9.4% sequentially and 36% from December 31, 2024. Nearly 80% of Q4 2025 revenue was derived from non-semiconductor end markets, reflecting successful diversification efforts. For the full year 2025, revenue was $113.8 million, a 12.9% decrease from $130.7 million in 2024. Full year 2025 resulted in a net loss of $(2.5) million, or $(0.21) per diluted share, compared to net earnings of $2.9 million, or $0.24 per diluted share, in 2024. The company reduced total debt by $7.6 million during 2025 and generated $7.3 million cash from operations.